Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-05-01 @ 8:53 PM
Study NCT ID:
NCT06330012
Status:
RECRUITING
Last Update Posted:
2024-03-26
First Post:
2024-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
Sponsor:
Organization: